CAS No. |
1423821-88-8 |
|---|---|
中文名称 |
20-[(1H-咪唑-5-基)甲基]-23-[(1H-吲哚-3-基)甲基]-8-苄基-26-(仲丁基)-11-(2-羧乙基)-17-(羧甲基)-29-[[(5-甲酰胺基-3,4-二氧代-1-苯基戊-2-基)氨基]甲酰基]-2-(1-羟乙基)-4,7,10,13,16,19,22,27-八氧代-3,6,9,12,15,18,21,24,25,28-十氮杂三十二烷二酸 |
英文名称 |
20-((1H-imidazol-5-yl)methyl)-23-((1H-indol-3-yl)methyl)-8-benzyl-26-(sec-butyl)-11-(2-carboxyethyl)-17-(carboxymethyl)-29-((5-formamido-3,4-dioxo-1-phenylpentan-2-yl)carbamoyl)-2-(1-hydroxyethyl)-4,7,10,13,16,19,22,27-octaoxo-3,6,9,12,15,18,21,24,25,28-decaazadotriacontanedioic acid |
别名 |
Tat-Beclin 1 Peptide;Tat-beclin 1 (Tat-BECN1) |
标准英文名 |
20-((1H-imidazol-5-yl)methyl)-23-((1H-indol-3-yl)methyl)-8-benzyl-26-(sec-butyl)-11-(2-carboxyethyl)-17-(carboxymethyl)-29-((5-formamido-3,4-dioxo-1-phenylpentan-2-yl)carbamoyl)-2-(1-hydroxyethyl)-4,7,10,13,16,19,22,27-octaoxo-3,6,9,12,15,18,21,24,25,28-decaazadotriacontanedioic acid |
分子式 |
C66H83N15O21 |
分子量 |
1422.47 |
精确分子量 |
1421.59 |
SMILES |
CCC(C)C(NNC(CC1=CNC2=CC=CC=C12)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NCC(=O)NC(C(=O)O)C(C)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)C(=O)CNC=O |
标准SMILES |
CCC(C)C(NNC(CC1=CNC2=CC=CC=C12)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(O)=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CC1C=CC=CC=1)C(=O)NCC(=O)NC(C(C)O)C(O)=O)C(=O)NC(CCC(O)=O)C(=O)NC(CC1C=CC=CC=1)C(=O)C(=O)CNC=O |
用途 |
Induces autophagy by mobilizing endogenous Beclin1; enhances clinical outcomes in West Nile virus (WNV)-infected mice; inhibits HIV-1 replication in human primary monocyte-derived macrophages; induces autophagy in peripheral tissues of adult mice and in the central nervous system of neonatal mice. |
InChIKey |
QQPORJWPQLZFOI-UHFFFAOYSA-N |
|
|
评论 |
|---|